10
Dec 2021
Latest News
Arise Biotech Received Subsidies from the Ministry of Economic Affairs; it Plans to Expand Sales Channels in Europe and the U.S. in 2022
Arise Biotech Corporation, as a provider of innovative and high-quality equipment of life science, a developer and a manufacturer of reagents and consumables, announced that it received the 2022 annual subsidy from the Bureau of Foreign Trade, Ministry of Economic Affairs. Arise Biotech will set up new offices in the U.S., the U.K. and the EU to provide real-time maintenance and product shipment in small amount in key regional markets to promote Taiwan brands that produce life science equipment at the international market and to improve sales volume in the future and quality of services in the meantime.
James Lo, General Manager of Arise Biotech, said that: “With 20 years of history, we believe in the importance of the value of innovation and marketing strategy. We’ve accumulated rich experience in product development for the European and American markets starting with fully customized ODM services so that we can predict the feasibility of product development with precision and meet personalized needs of multiple international brands. Then, we’ve set up multiple product lines completely manufactured in Taiwan to diversify our products and expand sales channels pro-actively. At this stage, we’re employing the local competitiveness of our own brand at the international market. We believe that our team can realize their full potential with the support from the Ministry of Economic Affairs for the overseas promotion.”
Arise Biotech plans to set up new offices in the European and American markets this year to expand our reach in the international market delicately and steadily. The company will deploy its sales and services resources flexibly through diverse online and offline marketing strategies to enhance the visibility and competitiveness of Taiwan brands.
Over 130 outstanding companies were on the list for government subsidies. Arise Biotech stands out with its innovative technologies and diverse integrated market strategies. The company hopes that it could provide a full range of lab equipment and professional ODM services to life science researchers around the globe.
James Lo, General Manager of Arise Biotech, said that: “With 20 years of history, we believe in the importance of the value of innovation and marketing strategy. We’ve accumulated rich experience in product development for the European and American markets starting with fully customized ODM services so that we can predict the feasibility of product development with precision and meet personalized needs of multiple international brands. Then, we’ve set up multiple product lines completely manufactured in Taiwan to diversify our products and expand sales channels pro-actively. At this stage, we’re employing the local competitiveness of our own brand at the international market. We believe that our team can realize their full potential with the support from the Ministry of Economic Affairs for the overseas promotion.”
Arise Biotech plans to set up new offices in the European and American markets this year to expand our reach in the international market delicately and steadily. The company will deploy its sales and services resources flexibly through diverse online and offline marketing strategies to enhance the visibility and competitiveness of Taiwan brands.
Over 130 outstanding companies were on the list for government subsidies. Arise Biotech stands out with its innovative technologies and diverse integrated market strategies. The company hopes that it could provide a full range of lab equipment and professional ODM services to life science researchers around the globe.
